Amicus Therapeutics Inc.

7.36
0.16 (2.22%)
At close: Apr 25, 2025, 3:59 PM
7.38
0.34%
After-hours: Apr 25, 2025, 05:51 PM EDT

Amicus Therapeutics Revenue

Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending December 31, 2024, Amicus Therapeutics generated $149.71M in revenue.
Revenue (ttm)
$528.29M
Revenue Growth
32.29%
Price / Sales Ratio
5.43
Revenue / Employee
$1.06M
Employees
499
Market Cap
2.26B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 528.29M +32.29%
Dec 31, 2023 399.36M +21.30%
Dec 31, 2022 329.23M +7.76%
Dec 31, 2021 305.51M +17.11%
Dec 31, 2020 260.89M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.